Newsroom

How a young Peninsula company snagged a onetime Roche exec to battle sepsis

Dec 19, 2017

Diagnosis: Frontiers in blood testing

Sep 28, 2017

Wanted: More Data, the Dirtier the Better. Embracing messy data as a way to capture the messiness of disease

Jun 12, 2017

Stanford Spinout Inflammatix Developing Sepsis Diagnostic Based on Host Immune Response

May 24, 2017

Researchers at the Stanford School of Medicine Develop Cutting-Edge Test to Identify Whether an Infection is Bacterial or Viral

Oct 24, 2016

A Blood Test to Determine when Antibiotics are Warranted

Jul 6, 2016

Do You Really Need Antibiotics? This Test Can Tell.

Jul 6, 2016

Simple blood test distinguishes between viral, bacterial infections

Jul 6, 2016

Interview with Tim Sweeney, MD, PhD, Co-Founder of Inflammatix (begins @ 19:40)

Jul 28, 2015

Inflammatix Checks off All the Right Boxes with Investors

Mar 19, 2021

Inflammatix nets $102M to advance its immune system tests for infectious diseases

Mar 16, 2021

Infection-detection system from Peninsula company scores $102M, aims to hit market this year

Mar 16, 2021

Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force

Mar 18, 2020

Inflammatix named to Fierce 15 MedTech list

Mar 9, 2020

New Technologies Can Step Up Fight Against Antimicrobial Resistance and Sepsis

Jan 10, 2020

Inflammatix raises $32M, plus a BARDA contract, for its point-of-care infection diagnostics

Jan 10, 2020

Inflammatix Raises $32M in Series C Financing

Jan 10, 2020

Genetic platform takes the guesswork out of catching infections

Dec 4, 2019